Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$43.45 - $53.66 $31,327 - $38,688
721 Added 18.49%
4,621 $239,000
Q2 2023

Aug 11, 2023

BUY
$42.28 - $51.43 $164,892 - $200,577
3,900 New
3,900 $200,000
Q2 2022

Aug 12, 2022

BUY
$57.25 - $86.63 $2.04 Million - $3.09 Million
35,697 New
35,697 $2.23 Million
Q1 2020

May 14, 2020

SELL
$34.22 - $76.49 $209,597 - $468,501
-6,125 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$68.92 - $85.27 $7,512 - $9,294
-109 Reduced 1.75%
6,125 $462,000
Q3 2019

Nov 13, 2019

SELL
$71.74 - $86.35 $4,232 - $5,094
-59 Reduced 0.94%
6,234 $460,000
Q2 2019

Aug 08, 2019

SELL
$66.45 - $97.36 $803,314 - $1.18 Million
-12,089 Reduced 65.77%
6,293 $453,000
Q1 2019

May 13, 2019

BUY
$86.15 - $100.49 $681,274 - $794,674
7,908 Added 75.5%
18,382 $1.79 Million
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $384,772 - $573,545
-4,573 Reduced 30.39%
10,474 $958,000
Q3 2018

Nov 13, 2018

SELL
$101.02 - $130.95 $3.02 Million - $3.91 Million
-29,868 Reduced 66.5%
15,047 $1.87 Million
Q2 2018

Aug 13, 2018

SELL
$81.75 - $105.37 $4.97 Million - $6.4 Million
-60,739 Reduced 57.49%
44,915 $4.48 Million
Q1 2018

May 14, 2018

BUY
$79.95 - $89.74 $7.12 Million - $7.99 Million
89,009 Added 534.75%
105,654 $9.35 Million
Q4 2017

Feb 13, 2018

SELL
$71.8 - $88.21 $16,873 - $20,729
-235 Reduced 1.39%
16,645 $1.33 Million
Q3 2017

Nov 13, 2017

SELL
$60.32 - $70.06 $747,968 - $868,744
-12,400 Reduced 42.35%
16,880 $1.18 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-108,560 Reduced 78.76%
29,280 $1.8 Million
Q1 2017

Apr 17, 2019

SELL
N/A
-220,922 Reduced 61.58%
137,840 $6.76 Million
Q4 2016

Apr 17, 2019

BUY
N/A
148,380 Added 70.53%
358,762 $16.1 Million
Q3 2016

Apr 17, 2019

BUY
N/A
210,382
210,382 $12.6 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.57B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.